Bristol-Myers Squibb
BMY
#167
Rank
NZ$200.50 B
Marketcap
NZ$98.46
Share price
-1.08%
Change (1 day)
-3.83%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): NZ$5.12

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$5.09. In 2024 the company made an earnings per share (EPS) of NZ-$7.57 a decrease over its 2023 EPS that were of NZ$6.65.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$5.12-167.61%
2024NZ-$7.57-213.92%
2023NZ$6.6530.2%
2022NZ$5.10-6.04%
2021NZ$5.43-179.29%
2020NZ-$6.85-281.37%
2019NZ$3.78-27.21%
2018NZ$5.19
2016NZ$4.57175.26%
2015NZ$1.66-19.83%
2014NZ$2.07-22.44%
2013NZ$2.6734.48%
2012NZ$1.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.08 275.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.61 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.33-54.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.10-19.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.43 675.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.55 382.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.54-30.47%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$18.82 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.52 146.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$9.16 80.13%๐Ÿ‡ฌ๐Ÿ‡ง UK